Estée Lauder Companies
EL NYSE Personal Care Products Financials FY2017–FY2026
Estée Lauder Companies' revenue rose 5.0% to $15.0 billion in fiscal 2026. Its operating margin was 5.2%, up from −5.5% a year earlier. Free cash flow was $1.3 billion, up 96.4%. It paid out $578 million in dividends and buybacks, 44% of free cash flow. The diluted share count rose 1.3%.
About these figures. Total debt is the balance sheet's long-term debt plus its current debt line.
What Estée Lauder Companies does
No business description yet.
- Legal name
- THE ESTEE LAUDER COMPANIES INC.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- —
- Accession · CIK
- 0001001250-26-000041
0001001250
Revenue and margins
Estée Lauder Companies had $15.0B of revenue in fiscal 2026, up 5.1% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew −19.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.3B in fiscal 2026, 8.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Estée Lauder Companies returned $578M to shareholders in fiscal 2026, 44% of free cash flow. The diluted share count rose 1.3%.
Value Estée Lauder Companies yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.
Discounted cash flow
Value per share
—
Adds net cash of −$3.8B and divides by 364.8M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
—
Reference multiples: today — · peers 24.3x · sector 24.3x.
Balance sheet
Cash, debt and the ratios that show how comfortably Estée Lauder Companies can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $4.0B | $4.0B | $3.4B | $2.9B | $3.5B |
| Debt incl. finance leases | $5.4B | $8.1B | $7.8B | $7.3B | $7.3B |
| Net debt / EBITDA | 0.4x | 1.8x | 2.4x | 99.9x | 2.4x |
| Debt / equity | 1.0x | 1.5x | 1.5x | 1.9x | 1.9x |
| Interest coverage | 19.0x | 5.9x | 2.6x | −2.2x | 2.3x |
| Current ratio | 1.6x | 1.5x | 1.4x | 1.3x | 1.2x |
| Quick ratio | 1.1x | 1.0x | 1.0x | 0.9x | 0.9x |
| Total assets | $20.9B | $23.4B | $21.7B | $19.9B | $19.8B |
| Total liabilities | $15.3B | $17.8B | $16.4B | $16.0B | $16.0B |
| Shareholders' equity | $5.6B | $5.6B | $5.3B | $3.9B | $3.8B |
| Net debt (− = net cash) | $1.5B | $4.1B | $4.4B | $4.4B | $3.8B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$1.0B
9 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Paul J FribourgDirector | Sold | 58,000 | $98.17 | $5.7M | Form 4 |
| Sep 11, 2026 | Paul J FribourgDirector | Sold | 45,000 | $96.78 | $4.4M | Form 4 |
| Sep 9, 2026 | Charlene BarshefskyDirector | Sold | 3,775 | $98.82 | $0.4M | Form 4 |
| Aug 28, 2026 | Lande Rashida LaExec VP & General Counsel | Sold | 7,766 | $103.32 | $0.8M | Form 4 |
| Aug 21, 2026 | Lande Rashida LaExec VP & General Counsel | Sold | 5,564 | $99.55 | $0.6M | Form 4 |
| Nov 26, 2025 | Jane LauderDirector, 10% owner | Sold | 17,840 | $94.38 | $1.7M | Form 4 |
| Nov 26, 2025 | Lande Rashida LaExec VP & General Counsel | Sold | 1,604 | $94.45 | $0.2M | Form 4 |
| Nov 18, 2025 | Meridith WebsterExec VP GlobalComm/PubAffairs | Sold | 5,430 | $87.84 | $0.5M | Form 4 |
| Nov 11, 2025 | Barry S SternlichtDirector | Sold | 3,972 | $91.83 | $0.4M | Form 4 |
| Nov 6, 2025 | Evelyn H. Lauder 2012 Marital Trust Two10% owner | Sold | 2,845,283 | $89.70 | $255M | Form 4 |
| Nov 6, 2025 | LAL 2015 ELF Trust10% owner | Sold | 5,670,000 | $89.70 | $509M | Form 4 |
| Nov 6, 2025 | Leonard A. Lauder 2013 Revocable Trust10% owner | Sold | 2,786,040 | $89.70 | $250M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | ✓ | ✕ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ |
| Return on assets rose | ✕ | ✕ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ |
| Debt fell relative to assets | ✓ | ✕ | ✕ |
| Current ratio rose | ✕ | ✕ | ✕ |
| Share count didn't rise | ✓ | ✓ | ✕ |
| Gross margin rose | ✓ | ✓ | ✓ |
| Revenue rose relative to assets | ✕ | ✕ | ✓ |
| F-score | 6 / 9 | 4 / 9 | 6 / 9 |
| Accruals ratio | −8.7% | −11.6% | −8.0% |
| Altman Z'' | 3.33 | 2.44 | 2.84 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Estée Lauder Companies EL | $39.6B | 5.1% | 5.2% | 8.7% | 4.9% | — | 6 | |
| Kenvue KVUE | $37.6B | −2.1% | 16.0% | 11.4% | 10.0% | 22.5x | 6 | Compare → |
| Coty COTY | $2.8B | −1.5% | −1.4% | 6.0% | −1.0% | — | 3 | Compare → |
| Procter & Gamble PG | $387.6B | 3.3% | 22.7% | 17.4% | 20.1% | 24.3x | 6 | Compare → |
| e.l.f. Beauty ELF | $6.8B | 24.6% | 4.5% | 11.6% | 3.8% | 114.2x | 4 | Compare → |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $11.8B | $13.7B | $14.9B | $14.3B | $16.2B | $17.7B | $15.9B | $15.6B | $14.3B | $15.0B |
| Gross profit | $9.4B | $10.8B | $11.5B | $10.7B | $12.4B | $13.4B | $11.3B | $11.2B | $10.6B | $11.4B |
| Operating income | $1.7B | $2.1B | $2.3B | $606M | $2.6B | $3.2B | $1.5B | $970M | −$785M | $780M |
| Interest expense | $103M | $128M | $133M | $161M | $173M | $167M | $255M | $378M | $357M | $334M |
| Pretax income | $1.6B | $2.0B | $2.3B | $1.0B | $3.3B | $3.0B | $1.4B | $772M | −$1.0B | $517M |
| Income tax | $361M | $863M | $513M | $350M | $456M | $628M | $387M | $363M | $93.0M | $335M |
| Net income | $1.2B | $1.1B | $1.8B | $684M | $2.9B | $2.4B | $1.0B | $409M | −$1.1B | $182M |
| Diluted EPS | $3.35 | $2.95 | $4.82 | $1.86 | $7.79 | $6.55 | $2.79 | $1.08 | −$3.15 | $0.50 |
| Diluted shares | 0.37B | 0.38B | 0.37B | 0.37B | 0.37B | 0.36B | 0.36B | 0.36B | 0.36B | 0.36B |
| Cash flow | ||||||||||
| Cash from operations | $1.8B | $2.6B | $2.5B | $2.3B | $3.6B | $3.0B | $1.7B | $2.4B | $1.3B | $1.8B |
| Capital expenditure | $504M | $629M | $744M | $623M | $637M | $1.0B | $1.0B | $919M | $602M | $457M |
| Free cash flow | $1.3B | $1.9B | $1.8B | $1.7B | $3.0B | $2.0B | $728M | $1.4B | $670M | $1.3B |
| Depreciation and amortization | $464M | $531M | $557M | $611M | $651M | $727M | $744M | $825M | $829M | $796M |
| Stock-based compensation | $219M | $236M | $243M | $213M | $327M | $331M | $267M | $325M | $304M | $310M |
| Acquisitions | $1.7B | $0.0M | $0.0M | $1.0B | $1.1B | $3.0M | $0.0M | $0.0M | $0.0M | $5.0M |
| Share buybacks | $413M | $759M | $1.6B | $893M | $733M | $2.3B | $271M | $35.0M | $35.0M | $70.0M |
| Dividends paid | $486M | $546M | $609M | $503M | $753M | $840M | $925M | $947M | $618M | $508M |
| Dividends and buybacks | $899M | $1.3B | $2.2B | $1.4B | $1.5B | $3.1B | $1.2B | $982M | $653M | $578M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.7B | $2.7B | — | $5.0B | $5.0B | $4.0B | $4.0B | $3.4B | $2.9B | $3.5B |
| Total debt | $3.6B | $3.5B | $3.4B | $6.1B | $5.6B | $5.4B | $8.1B | $7.8B | $7.3B | $7.3B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $13.0M | $45.0M | $23.0M | $42.0M | $32.0M | $31.0M | $28.0M |
| Current assets | $5.0B | $6.2B | $7.2B | $8.9B | $9.8B | $9.3B | $9.1B | $7.9B | $7.1B | $7.6B |
| Current liabilities | $2.8B | $3.3B | $4.6B | $5.2B | $5.3B | $5.8B | $6.2B | $5.7B | $5.4B | $6.2B |
| Inventory | $1.5B | $1.6B | $2.0B | $2.1B | $2.5B | $2.9B | $3.0B | $2.2B | $2.1B | $2.0B |
| Property and equipment, net | $1.7B | $1.8B | $2.1B | $2.1B | $2.3B | $2.7B | $3.2B | $3.1B | $3.2B | $2.8B |
| Total assets | $11.6B | $12.6B | $13.2B | $17.8B | $22.0B | $20.9B | $23.4B | $21.7B | $19.9B | $19.8B |
| Total liabilities | $7.2B | $7.9B | $8.7B | $13.8B | $15.9B | $15.3B | $17.8B | $16.4B | $16.0B | $16.0B |
| Shareholders' equity | $4.4B | $4.7B | $4.4B | $3.9B | $6.1B | $5.6B | $5.6B | $5.3B | $3.9B | $3.8B |
| Margins | ||||||||||
| Gross margin | 79.4% | 79.2% | 77.2% | 75.2% | 76.4% | 75.7% | 71.3% | 71.7% | 74.0% | 75.5% |
| Operating margin | 14.4% | 15.0% | 15.6% | 4.2% | 16.2% | 17.9% | 9.5% | 6.2% | −5.5% | 5.2% |
| EBITDA margin | 18.3% | 18.9% | 19.3% | 8.5% | 20.2% | 22.0% | 14.2% | 11.5% | 0.3% | 10.5% |
| Net margin | 10.6% | 8.1% | 12.0% | 4.8% | 17.7% | 13.6% | 6.4% | 2.6% | −7.9% | 1.2% |
| FCF margin | 10.9% | 14.1% | 11.9% | 11.6% | 18.5% | 11.3% | 4.6% | 9.2% | 4.7% | 8.7% |
| Returns | ||||||||||
| Return on capital | 24.8% | 19.7% | — | — | 38.4% | 36.6% | 13.1% | 5.3% | −6.9% | 4.9% |
| Return on capital employed | 22.3% | 22.8% | 26.0% | 5.7% | 17.9% | 20.0% | 9.4% | 5.9% | −5.2% | 5.6% |
| Return on equity | 31.4% | 24.4% | 39.3% | 16.4% | 57.6% | 41.4% | 18.1% | 7.5% | −24.7% | 4.8% |
| Return on assets | 12.0% | 9.2% | 13.9% | 4.4% | 14.5% | 11.2% | 4.6% | 1.8% | −5.5% | 0.9% |
| Growth | ||||||||||
| Revenue growth | 5.0% | 15.7% | 8.6% | −3.8% | 13.4% | 9.4% | −10.3% | −1.9% | −8.2% | 5.1% |
| Net income growth | 12.0% | −11.3% | 61.1% | −61.7% | 320.3% | −16.2% | −58.1% | −59.5% | −377.0% | — |
| EPS growth | 13.2% | −11.9% | 63.4% | −61.4% | 318.8% | −15.9% | −57.4% | −61.3% | −391.7% | — |
| FCF growth | 1.7% | 50.3% | −8.3% | −6.5% | 80.7% | −33.2% | −63.6% | 97.9% | −53.5% | 96.4% |
| Share count change | −1.0% | 0.7% | −1.4% | −0.9% | 0.4% | −0.9% | −1.1% | −0.0% | −0.2% | 1.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.8x | 0.3x | — | 0.9x | 0.2x | 0.4x | 1.8x | 2.4x | 99.9x | 2.4x |
| Debt / equity | 0.8x | 0.8x | 0.8x | 1.6x | 0.9x | 1.0x | 1.5x | 1.5x | 1.9x | 1.9x |
| Interest coverage | 16.5x | 16.1x | 17.4x | 3.8x | 15.1x | 19.0x | 5.9x | 2.6x | −2.2x | 2.3x |
| Current ratio | 1.8x | 1.9x | 1.6x | 1.7x | 1.8x | 1.6x | 1.5x | 1.4x | 1.3x | 1.2x |
| Quick ratio | 1.2x | 1.4x | 1.1x | 1.3x | 1.4x | 1.1x | 1.0x | 1.0x | 0.9x | 0.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 4.3% | 4.6% | 5.0% | 4.4% | 3.9% | 5.9% | 6.3% | 5.9% | 4.2% | 3.0% |
| Stock comp / revenue | 1.9% | 1.7% | 1.6% | 1.5% | 2.0% | 1.9% | 1.7% | 2.1% | 2.1% | 2.1% |
| Payouts / FCF | 69.9% | 67.5% | 122.1% | 84.3% | 49.6% | 157.5% | 164.3% | 68.2% | 97.5% | 43.9% |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 5.0 | 6.0 | 5.0 | 7.0 | 5.0 | 4.0 | 6.0 | 4.0 | 6.0 |
| Altman Z'' | 5.2 | 5.6 | 5.5 | 3.8 | 4.4 | 4.7 | 3.5 | 3.3 | 2.4 | 2.8 |
| Accruals ratio | −5.2% | −12.1% | −5.7% | −10.3% | −3.8% | −3.0% | −3.3% | −8.7% | −11.6% | −8.0% |
Source: SEC EDGAR XBRL filings (CIK 0001001250). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.